GPFT - Grapefruit USA, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0027
+0.0001 (+3.85%)
As of 09:30AM EDT. Market open.
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close0.0026
Open0.0027
BidN/A x N/A
AskN/A x N/A
Day's Range0.0027 - 0.0027
52 Week Range0.0016 - 0.0254
Volume375
Avg. Volume897,628
Market Cap1.937M
Beta (5Y Monthly)0.82
PE Ratio (TTM)N/A
EPS (TTM)-0.0000
Earnings DateApr 26, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for GPFT

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • GlobeNewswire

    Grapefruit USA, Inc. Provides Further Update on Diagnostic Lab Corporation Acquisition, Securing New Financing and Retail Store Plan

    LOS ANGELES and DESERT HOT SPRINGS, Calif., March 10, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTC: GPFT) (“Grapefruit” or the “Company”), an innovative California-based cannabiotech company, today updates its recent announcement regarding the proposed acquisition of Diagnostic Lab Corporation, Inc. of Englewood Cliffs, New Jersey (“DLC”), a diversified food and agriculture safety company, as well as the proposed recapitalization of the Company. On Aug. 18, 2022, the Co

  • GlobeNewswire

    Grapefruit USA, Inc. Provides Further Update on Diagnostic Lab Corporation, Inc. Acquisition, Securing New Financing

    LOS ANGELES and DESERT HOT SPRINGS, Calif., Nov. 21, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based cannabiotech company, is updating its recent announcement of the proposed acquisition of Diagnostic Lab Corporation of Englewood Cliffs, New Jersey (“DLC”), a diversified food and agriculture safety company, and the recapitalization of the Company. On Aug. 18, 2022, the Company reported that it was “fi

  • GlobeNewswire

    Hall of Fame Wrestler and Cannabis Pioneer Rob Van Dam to Launch RVD Cannabis Brand in California Through Licensing Deal with Grapefruit USA, Inc.

    LOS ANGELES and DESERT HOT SPRINGS, Calif., Sept. 29, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based cannabiotech company and cannabis distributor, today announces that it has entered into an exclusive licensing agreement with WWE Hall of Fame wrestler and cannabis pioneer Rob Van Dam to bring his branded cannabis products to the California retail marketplace. Rob Van Dam (“RVD”) is an American profe

  • GlobeNewswire

    Grapefruit USA, Inc. Provides Update on Diagnostic Lab Corporation, Inc. Acquisition, Secures New Financing

    LOS ANGELES and DESERT HOT SPRINGS, Calif., Aug. 18, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based cannabiotech company, today updates its recent announcement of the proposed acquisition of Diagnostic Lab Corporation of Englewood Cliffs, New Jersey (“DLC”), a diversified food and agriculture safety company, and also announces the recapitalization of the Company. The Company is finalizing its due dil

  • GlobeNewswire

    Grapefruit USA, Inc. Executes Binding Letter of Intent to Acquire Diagnostic Lab Corporation, Inc., Secure New Financing

    LOS ANGELES and DESERT HOT SPRINGS, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based cannabiotech company, announces today the execution of a binding letter of intent (“LOI”), entered into on June 30, 2022, by the Company and Diagnostic Lab Corporation of Englewood Cliffs, New Jersey, (“DLC”) a diversified food and agriculture safety company, pursuant to which the Company and DLC will